This week sees people on the move at INC Research, Novasep, Quintiles and beyond. Plus, we find out which CMO is hiring the inventor of Rituxan.
Contract research organisation INC Research has appointed two senior executives to its oncology team.
Asli Turkes becomes VP, clinical development and oncology, while Susan Timoney joins the company as Executive Director, clinical development and oncology.
Turkes is experienced in developing drugs from preclinical to Phase IV stages and beyond, having helped develop an orphan drug for Gaucher’s disease, and a monoclonal antibody class drug for breast cancer.
Timoney is a specialist in the research of solid and haematological tumours. For the last two years, she has led a company-wide initiative to transform project delivery at Quintiles.
Turkes will be based in INC's office in Camberley, while Timoney will work at its Scottish labs.
Copyright - Unless otherwise stated all contents of this web site are © 2014 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Recipharm, Catalent, INC and PRA completed eye-catching IPOs in 2014. Which firms are likely follow suit in 2015?
Catering for low value, high volume customers as well as the growing number of firms developing complex...
Clinverse, Intertek and inVentiv are among the pharma services companies announcing new staff this week.